News | August 18, 2025
European Commission grants approval of Ogsiveo
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Reinforcing commitment to ethical and sustainable growth
Cenexi reports an EBITDA breakeven for the quarter
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Subscribe To Our Newsletter & Stay Updated
